| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
|
JAMA
|
2001
|
24.12
|
|
2
|
A comparison of rate control and rhythm control in patients with atrial fibrillation.
|
N Engl J Med
|
2002
|
16.31
|
|
3
|
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.
|
Circulation
|
2006
|
11.78
|
|
4
|
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.
|
JAMA
|
1994
|
11.63
|
|
5
|
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2014
|
9.96
|
|
6
|
Dronedarone in high-risk permanent atrial fibrillation.
|
N Engl J Med
|
2011
|
8.93
|
|
7
|
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
|
Circulation
|
2004
|
8.80
|
|
8
|
Effect of dronedarone on cardiovascular events in atrial fibrillation.
|
N Engl J Med
|
2009
|
8.51
|
|
9
|
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
|
N Engl J Med
|
2002
|
8.37
|
|
10
|
Incidence of and risk factors for atrial fibrillation in older adults.
|
Circulation
|
1997
|
8.18
|
|
11
|
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.
|
Arch Intern Med
|
1995
|
7.83
|
|
12
|
Rhythm control versus rate control for atrial fibrillation and heart failure.
|
N Engl J Med
|
2008
|
6.17
|
|
13
|
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.
|
J Thromb Haemost
|
2005
|
5.92
|
|
14
|
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
|
N Engl J Med
|
2007
|
5.78
|
|
15
|
Amiodarone versus sotalol for atrial fibrillation.
|
N Engl J Med
|
2005
|
5.01
|
|
16
|
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
|
N Engl J Med
|
2000
|
4.27
|
|
17
|
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).
|
Am J Cardiol
|
1994
|
4.08
|
|
18
|
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
|
J Am Coll Cardiol
|
2009
|
3.54
|
|
19
|
Increased mortality after dronedarone therapy for severe heart failure.
|
N Engl J Med
|
2008
|
3.49
|
|
20
|
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
|
J Cardiovasc Electrophysiol
|
2010
|
3.24
|
|
21
|
Clinical classification of cardiac deaths.
|
Circulation
|
1982
|
2.93
|
|
22
|
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
|
Circulation
|
2009
|
2.57
|
|
23
|
Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
|
J Am Coll Cardiol
|
2011
|
2.42
|
|
24
|
Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.
|
J Am Coll Cardiol
|
2003
|
2.20
|
|
25
|
Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.
|
Circulation
|
1996
|
2.19
|
|
26
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2010
|
1.87
|
|
27
|
Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology.
|
Arch Intern Med
|
2000
|
1.67
|
|
28
|
Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
|
Am Heart J
|
2008
|
1.64
|
|
29
|
Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.40
|
|
30
|
Pragmatic Trials.
|
N Engl J Med
|
2016
|
1.34
|
|
31
|
Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
|
J Am Coll Cardiol
|
2010
|
1.18
|
|
32
|
Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit.
|
Am Heart J
|
2012
|
1.14
|
|
33
|
Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials.
|
Stat Med
|
2006
|
1.08
|
|
34
|
Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
|
J Cardiovasc Electrophysiol
|
2007
|
0.99
|
|
35
|
Interaction between digoxin and dronedarone in the PALLAS trial.
|
Circ Arrhythm Electrophysiol
|
2014
|
0.95
|
|
36
|
Decade-long trends in atrial fibrillation incidence and survival: a community study.
|
Am J Med
|
2014
|
0.92
|
|
37
|
Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.
|
Circ Cardiovasc Qual Outcomes
|
2014
|
0.86
|
|
38
|
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
|
Am Heart J
|
2007
|
0.84
|
|
39
|
Dronedarone and the incidence of stroke in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials.
|
Am J Cardiovasc Drugs
|
2011
|
0.83
|
|
40
|
Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).
|
Circ Cardiovasc Qual Outcomes
|
2014
|
0.80
|
|
41
|
Hospital readmissions in US atrial fibrillation patients: occurrence and costs.
|
Am J Ther
|
2013
|
0.80
|
|
42
|
Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites.
|
Am J Cardiol
|
2007
|
0.80
|
|
43
|
An alternative approach to confidence interval estimation for the win ratio statistic.
|
Biometrics
|
2014
|
0.79
|
|
44
|
Heart rate is associated with progression of atrial fibrillation, independent of rhythm.
|
Heart
|
2015
|
0.76
|
|
45
|
The value of cardiovascular hospitalization as an endpoint for clinical atrial fibrillation research.
|
Europace
|
2011
|
0.76
|
|
46
|
TEMPORARY REMOVAL: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation.
|
Heart Rhythm
|
2017
|
0.75
|
|
47
|
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
|
Eur Heart J
|
2020
|
0.75
|
|
48
|
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
|
J Am Coll Cardiol
|
2014
|
0.75
|